![]() |
WEBINAR |
Sponsored by Xybion
|
Wednesday, Dec. 2, 2020 | 1:30 p.m. - 2:30 p.m. EST |
Want to improve your clinical trial quality, compliance and risk management? Predictive technologies incorporating artificial intelligence (AI) and machine learning along with smart digital cloud platforms can provide valuable insights for better decision making.
With agencies adopting COVID-19 mitigation protocols such as clinical trial eSource and eAudit for GXP inspections, this free webinar is your opportunity to leverage such technologies and bring innovative products to market faster.
These digital tools capture the right data and enable clinical trial professionals to predict risks and prioritize actions to reduce the risks over time.
Use these tools to help start trials early by ensuring site operations are always ready through predictive compliance risk management implementation. You’ll identify and minimize risks in site nonconformance, vendor noncompliance and service deliveries. And you can use them to manage data integrity and understand related risks.
In this free webinar Pradip K. Banerjee, Ph.D., Xybion’s Chairman of the Board and Chief Executive Officer, and compliance and risk specialist Brian Friel and Bob Friedman, Chief Technologist will discuss and demonstrate predictive technologies using specific examples.
Webinar Takeaways:
These technologies will help you innovate your clinical trials, enhance quality, compliance and risk management. Join us by registering today for this free webinar.
Who Will Benefit:
Pradip K. Banerjee, Ph.D.
Chairman of the Board and Chief Executive Officer
Xybion
Pradip K. Banerjee, Ph.D. is Xybion’s Chairman of the Board and Chief Executive Officer. He is the founding Managing Partner (retired) of Accenture’s research and development line of business. He is an entrepreneurial senior executive with more than 30 years of in-depth experience in the global life sciences, healthcare and services industries in operations, strategic management, business development, investments and new venture creations. Previously, he held several research and development management positions at Abbott, Glaxo-Smith Kline and also served as president and CEO of the Science Center in Philadelphia.
Brian Friel
Compliance and Risk Specialist
Xybion
Brian Friel, who has more than 20 years of experience in the life sciences space, is a Senior Sales Executive and compliance and risk specialist at Xybion. He leads strategic engagements in manufacturing, quality and technology domains. Mr. Friel has been instrumental in guiding a number of key industry customers to a digital offering over the last 15 years, leveraging numerous technological advantages to vastly improve business operations and elevate customers as industry leaders.
Bob Friedman
Chief Technologist
Xybion
Bob Friedman has more than 25 years of experience in Preclinical information systems at Xybion Corporation as a developer, development manager and Chief Solution Architect. He has been an active member of the CDISC SEND standards consortium for five years as well as the PhUSE / FDA Industry Collaboration. Bob has previously worked for Synthes Orthopedics, NYU Medical Center and the New York State Department of Health.